Clinical Trial Update: Remimazolam for Bronchoscopy in High-Risk Patients [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update: remimazolam is being studied for sedation during bronchoscopy in high-risk patients, and the study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lymphadenopathy
• Pulmonary Infection
• Pulmonary Nodules
• Tracheal Tumor
• Tuberculosis

Drugs mentioned

• Remimazolam (remimazolam)

Snippet

Sponsor: First Affiliated Hospital of Zhejiang University | Conditions: Pulmonary Infection, Pulmonary Nodule | Phase 4 | Status: RECRUITING